IP Library Granted Patent US 7,361,469
Granted Patent B2
US 7,361,469 · App. 11/203,320 · Granted Apr 22, 2008

Dual labeled fluorescent probes

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,361,469
App. No.
11/203,320
Granted
Apr 22, 2008
Kind
B2
Abstract

The present invention relates to probes useful for the detection and measurement of target nucleic acids, as well as compositions and kits containing such probes. The probes of the present invention include an interactive pair of labels, as well as a hairpin sequence that does not hybridize to a target nucleic acid. According to the present invention, the probe generates a detectable signal indicative of a presence of a target nucleic acid. The detectable signal emitted by one of the pair of labels is substantially constant upon binding of the probe to target nucleic acid, and the detectable signal increases by at least 2 fold upon cleavage of the probe between the pair of labels.

Claims (64)

1. An oligonucleotide probe having a 5′ and 3′ end, comprising:

(a) a hairpin sequence that does not hybridize to a target nucleic acid and consisting of a stem and a loop;

(b) a target binding sequence that forms a hybrid with a target nucleic acid; and,

(c) an interactive pair of labels, consisting of a first and second member; wherein said hairpin sequence and said target binding sequence are covalently linked, wherein said first member of said pair is attached anywhere in said probe outside of said hairpin sequence and wherein said second member of said pair is attached to said target binding sequence at the terminus distal to said hairpin sequence, wherein a detectable signal is emitted by one of said pair of labels, and wherein said detectable signal increases by at least 2 fold upon cleavage of said probe between said pair.

2. The probe of claim 1 , further comprising a linker sequence, located between said hairpin sequence and said target binding sequence.

3. The probe of claim 2 , wherein said linker sequence comprises between 1 and 15 nucleotides.

4. The probe of claim 2 , wherein said linker sequence comprises between 1 and 10 nucleotides.

5. The probe of claim 2 , wherein said linker sequence comprises between 1 and 5 nucleotides.

6. The probe of claim 1 , wherein said pair comprises a fluorophore and a quencher.

7. The probe of claim 6 , wherein of one of said fluorophore or said quencher is attached to said 3′ nucleotide such that said probe does not serve as a template for synthesis.

8. The probe of claim 7 , wherein said fluorophore is attached to said 3′ nucleotide.

9. The probe of claim 1 , wherein said pair is separated by between 5 and 60 nucleotides.

10. The probe of claim 1 , wherein said pair is separated by between 10 and 30 nucleotides.

11. The probe of claim 6 , wherein said fluorophore is selected from the group consisting of FAM, R110, TAMRA, R6G, CAL Fluor Red 610, CAL Fluor Gold 540, and CAL Fluor Orange 560.

12. The probe of claim 6 , wherein said quencher is selected from the group consisting of DABCYL, BHQ-1, BHQ-2, and BHQ-3.

13. The probe of claim 6 , wherein said fluorescence increases upon cleavage of said probe between said fluorophore and quencher by at least 3 fold.

14. The probe of claim 6 , wherein said fluorescence increases upon cleavage of said probe between said fluorophore and quencher by at least 4 fold.

15. The probe of claim 1 , wherein said stem of said hairpin sequence is between 2 to 20 base pairs.

16. The probe of claim 1 , wherein said stem of said hairpin sequence is between 3 to 10 base pairs.

17. The probe of claim 1 , wherein said stem of said hairpin sequence is between 4 to 8 base pairs.

18. The probe of claim 1 , wherein said loop of said hairpin sequence is between 2 and 30 bases.

19. The probe of claim 1 , wherein said loop of said hairpin sequence is between 3 and 20 bases.

20. The probe of claim 1 , wherein said loop of said hairpin sequence is between 3 and 10 bases.

21. The probe of claim 6 , wherein one of said fluorophore or quencher is attached at the 3′ OH moiety of said target binding sequence.

22. The probe of claim 6 , wherein one of said fluorophore or quencher is attached to the linker sequence.

23. The probe of claim 6 , wherein one of said fluorophore or quencher is attached to the target binding sequence.

24. The probe of claim 6 , wherein said fluorophore or quencher is directly attached.

25. The probe of claim 6 , wherein said fluorophore or quencher is indirectly attached via a spacer.

26. The probe of claim 6 , further comprising a solid support.

27. The probe of claim 26 , wherein said solid support is attached to the 5′ end of said hairpin sequence.

28. An oligonucleotide probe having a 5′ and 3′ end, comprising:

(a) a hairpin sequence that does not hybridize to a target nucleic acid and consisting of a stem and a loop;

(b) a target binding sequence that forms a hybrid with a target nucleic acid; and,

(c) an interactive pair of labels, consisting of a first and second member; wherein said hairpin sequence and said target binding sequence are covalently linked such that said hairpin sequence is positioned 5′ of said target binding sequence, wherein said first member of said pair is attached to the 3′ terminus of said target binding sequence and wherein said second member of said pair is attached to said oligonucleotide probe between said 3′ terminus and said hairpin sequence, and wherein a detectable signal is emitted by one of said pair of labels, and wherein said signal increases by at least 2 fold upon cleavage of said probe between said pair.

29. An oligonucleotide probe having a 5′ and 3′ end, comprising:

(a) a hairpin sequence that does not hybridize to a target nucleic acid and consisting of a stem and a loop;

(b) a target binding sequence that forms a hybrid with a target nucleic acid; and,

(c) an interactive pair of labels, consisting of a first and second member; wherein said hairpin sequence and said target binding sequence are covalently linked such that said hairpin sequence is positioned 3′ of said target binding sequence; wherein said first member of said pair is attached to the 5′ terminus of said target binding sequence and wherein said second member of said pair is attached to said oligonucleotide probe between the 3′ terminus of said target binding sequence and said hairpin sequence; wherein a detectable signal is emitted by one of said pair of labels; and wherein said detectable signal increases by at least 2 fold upon cleavage of said probe between said pair.

30. A composition comprising the probe of claim 1 and a primer.

31. The composition of claim 30 , further comprising a nucleic acid polymerase.

32. The composition of claim 31 , wherein said nucleic acid polymerase is a DNA polymerase.

33. The composition of claim 31 , wherein said nucleic acid polymerase substantially lacks 5′ to 3′ exonuclease activity.

34. The composition of claim 31 , further comprising FEN nuclease.

35. A composition comprising the probe of claim 1 , and a nucleic acid polymerase.

36. The composition of claim 35 , wherein said nucleic acid polymerase substantially lacks 5′ to 3′ exonuclease activity.

37. The composition of claim 35 , further comprising a FEN nuclease.

38. The composition of claim 35 , further comprising a primer.

39. A kit for generating a signal indicative of the presence of a target nucleic acid sequence in a sample, comprising the probe of claim 1 , a nucleic acid polymerase substantially lacking 5′ to 3′ exonuclease activity, and packaging material therefore.

40. The kit of claim 39 , further comprising a suitable buffer.

41. The kit of claim 39 , further comprising a FEN nuclease.

42. The kit of claim 39 , further comprising a primer.

43. A kit for generating a signal indicative of the presence of a target nucleic acid sequence in a sample, comprising the probe of claim 1 , a FEN nuclease, and packaging material therefore.

44. The kit of claim 43 , further comprising a suitable buffer.

45. The kit of claim 43 , further comprising a nucleic acid polymerase substantially lacking 5′ to 3′ exonuclease activity.

46. The kit of claim 43 , further comprising a primer.

47. A kit for generating a signal indicative of the presence of a target nucleic acid sequence in a sample, comprising the probe of claim 1 , a primer, and packaging material therefore.

48. The kit of claim 47 , further comprising a suitable buffer.

49. The kit of claim 47 , further comprising a nucleic acid polymerase substantially lacking 5′ to 3′ exonuclease activity.

50. The kit of claim 47 , further comprising a FEN nuclease.

51. The probe of claim 1 , wherein the detectable signal emitted by one of said pair of labels is substantially constant upon binding of said probe to target nucleic acid.

52. The probe of claim 28 , wherein the detectable signal emitted by one of said pair of labels is substantially constant upon binding of said probe to target nucleic acid.

53. The probe of claim 29 , wherein the detectable signal by one of said pair of labels is substantially constant upon binding of said probe to target nucleic acid.

54. The probe of claim 28 , further comprising a linker sequence, located between said hairpin sequence and said target binding sequence.

55. The probe of claim 28 , wherein said pair comprises a fluorophore and a quencher.

Assignments (11)
RELEASE OF SECURITY INTEREST Recorded Apr 28, 2026
From: BANK OF AMERICA, N.A., AS COLLATERAL AGENT
To: HOLOGIC, INC., ON ITS OWN BEHALF AND AS SUCCESSOR-BY-MERGER TO DIRECT RADIOGRAPHY CORP.; CYTYC CORPORATION, ON ITS OWN BEHALF AND AS SUCCESSOR-BY-MERGER TO BIOLUCENT, LLC; CYTYC SURGICAL PRODUCTS, LLC, AS SUCCESSOR-BY-CONVERSION TO CYTYC SURGICAL PRODUCTS, LIMITED PARTNERSHIP; GEN-PROBE INCORPORATED, ON ITS OWN BEHALF AND AS SUCCESSOR-BY-MERGER TO THIRD WAVE TECHNOLOGIES, INC.; GEN-PROBE PRODESSE, INC.; SUROS SURGICAL SYSTEMS, INC.
Reel/Frame 075566/0039 →
CORRECTIVE ASSIGNMENT TO CORRECT THE INCORRECT PATENT NO. 8081301 PREVIOUSLY RECORDED AT REEL: 035820 FRAME: 0239. ASSIGNOR(S) HEREBY CONFIRMS THE SECURITY INTEREST RELEASE. Recorded Nov 9, 2017
From: GOLDMAN SACHS BANK USA, AS COLLATERAL AGENT
To: HOLOGIC, INC.; BIOLUCENT, LLC; CYTYC CORPORATION; CYTYC SURGICAL PRODUCTS, LIMITED PARTNERSHIP; SUROS SURGICAL SYSTEMS, INC.; THIRD WAVE TECHNOLOGIES, INC.; GEN-PROBE INCORPORATED
Reel/Frame 044727/0529 →
CORRECTIVE ASSIGNMENT TO CORRECT THE INCORRECT PATENT NO. 8081301 PREVIOUSLY RECORDED AT REEL: 028810 FRAME: 0745. ASSIGNOR(S) HEREBY CONFIRMS THE SECURITY AGREEMENT. Recorded Nov 9, 2017
From: HOLOGIC, INC.; BIOLUCENT, LLC; CYTYC CORPORATION; CYTYC SURGICAL PRODUCTS, LIMITED PARTNERSHIP; SUROS SURGICAL SYSTEMS, INC.; THIRD WAVE TECHNOLOGIES, INC.; GEN-PROBE INCORPORATED
To: GOLDMAN SACHS BANK USA
Reel/Frame 044432/0565 →
SECURITY AGREEMENT Recorded Aug 7, 2015
From: HOLOGIC, INC.; BIOLUCENT, LLC; CYTYC CORPORATION; CYTYC SURGICAL PRODUCTS, LIMITED PARTNERSHIP; DIRECT RADIOGRAPHY CORP.; GEN-PROBE INCORPORATED; GEN-PROBE PRODESSE, INC.; SUROS SURGICAL SYSTEMS, INC.; THIRD WAVE TECHNOLOGIES, INC.
To: BANK OF AMERICA, N.A., AS COLLATERAL AGENT
Reel/Frame 036307/0199 →
SECURITY INTEREST RELEASE REEL/FRAME 028810/0745 Recorded Jun 4, 2015
From: GOLDMAN SACHS BANK USA, AS COLLATERAL AGENT
To: HOLOGIC, INC.; BIOLUCENT, LLC; CYTYC CORPORATION; CYTYC SURGICAL PRODUCTS, LIMITED PARTNERSHIP; SUROS SURGICAL SYSTEMS, INC.; THIRD WAVE TECHNOLOGIES, INC.; GEN-PROBE INCORPORATED
Reel/Frame 035820/0239 →
SECURITY AGREEMENT Recorded Aug 1, 2012
From: HOLOGIC, INC.; BIOLUCENT, LLC; CYTYC CORPORATION; CYTYC SURGICAL PRODUCTS, LIMITED PARTNERSHIP; SUROS SURGICAL SYSTEMS, INC.; THIRD WAVE TECHNOLOGIES, INC.; GEN-PROBE INCORPORATED
To: GOLDMAN SACHS BANK USA
Reel/Frame 028810/0745 →
CONFIRMATORY LICENSE Recorded Jan 20, 2011
From: THE OHIO STATE UNIVERSITY RESEARCH FOUNDATION
To: NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT
Reel/Frame 025664/0295 →
TERMINATION OF PATENT SECURITY AGREEMENTS AND RELEASE OF SECURITY INTERESTS Recorded Aug 26, 2010
From: GOLDMAN SACHS CREDIT PARTNERS, L.P., AS COLLATERAL AGENT
To: HOLOGIC, INC.; R2 TECHNOLOGY, INC.; SUROS SURGICAL SYSTEMS, INC.; BIOLUCENT, LLC; DIRECT RADIOGRAPHY CORP.; CYTYC SURGICAL PRODUCTS II LIMITED PARTNERSHIP; CYTYC SURGICAL PRODUCTS LIMITED PARTNERSHIP; CYTYC CORPORATION; CYTYC SURGICAL PRODUCTS III, INC.; CYTYC PRENATAL PRODUCTS CORP.; THIRD WAVE TECHNOLOGIES, INC.
Reel/Frame 024892/0001 →
EIGHTH SUPPLEMENT TO PATENT SECURITY AGREEMENT Recorded Mar 26, 2009
From: CYTYC CORPORATION; HOLOGIC, INC.
To: GOLDMAN SACHS CREDIT PARTNERSL.P.
Reel/Frame 022456/0947 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Dec 15, 2008
From: STRATAGENE CALIFORNIA
To: HOLOGIC INC.
Reel/Frame 021976/0268 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jan 9, 2006
From: SORGE, JOSEPH A.; MUELLER, REINHOLD; PADMABANDU, GOTHAMI
To: STRATAGENE CALIFORNIA
Reel/Frame 017436/0139 →